1. Home
  2. HALO vs KSPI Comparison

HALO vs KSPI Comparison

Compare HALO & KSPI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Halozyme Therapeutics Inc.

HALO

Halozyme Therapeutics Inc.

N/A

Current Price

$100.98

Market Cap

14.8B

Sector

Health Care

ML Signal

N/A

Logo Joint Stock Company Kaspi.kz

KSPI

Joint Stock Company Kaspi.kz

N/A

Current Price

$88.50

Market Cap

17.7B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
HALO
KSPI
Founded
1998
2008
Country
United States
Kazakhstan
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.8B
17.7B
IPO Year
2001
2023

Fundamental Metrics

Financial Performance
Metric
HALO
KSPI
Price
$100.98
$88.50
Analyst Decision
Buy
Buy
Analyst Count
9
7
Target Price
★ $119.89
$104.57
AVG Volume (30 Days)
★ 2.3M
476.9K
Earning Date
11-05-2026
11-09-2026
Dividend Yield
N/A
★ 10.01%
EPS Growth
N/A
★ N/A
EPS
★ 5.12
N/A
Revenue
★ $151,862,000.00
N/A
Revenue This Year
$35.97
$12.31
Revenue Next Year
$14.85
$19.33
P/E Ratio
$19.84
★ $7.12
Revenue Growth
N/A
N/A
52 Week Low
$61.23
$68.59
52 Week High
$134.00
$109.94

Technical Indicators

Market Signals
Indicator
HALO
KSPI
Relative Strength Index (RSI) 27.51 41.33
Support Level $64.08 $84.01
Resistance Level $111.15 $92.90
Average True Range (ATR) 4.64 2.61
MACD -3.78 -0.27
Stochastic Oscillator 6.04 18.46

Price Performance

Historical Comparison
HALO
KSPI

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. ENHANZE drug delivery technology was introduced with the proprietary enzyme rHuPH20, to facilitate the subcutaneous delivery of injected drugs and fluids, with the goal of improving the patient experience with rapid SC delivery and reduced treatment burden. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About KSPI Joint Stock Company Kaspi.kz

Kaspi.kz JSC is the payment, marketplace, and Fintech ecosystem in Kazakhstan. The firm provides interconnected technologically seamless products and services that help people to pay, shop and manage their finances. Its operating segment includes the Payments Platform that connects its customers, which consist of both consumers and merchants, to facilitate cashless, digital transactions, the Marketplace Platform, which derives maximum revenue, connects merchants and consumers enabling merchants to increase their sales and consumers to buy a broad selection of products and services offered by a variety of merchants, and Fintech Platform that enables customers to manage their personal finances online and access consumer finance and deposit products through the Kaspi.kz Super App.

Share on Social Networks: